NEUROSTAR TMS THERAPY SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-12-24 for NEUROSTAR TMS THERAPY SYSTEM manufactured by Neuronetics.

Event Text Entries

[34702492] Starting from (b)(6) 2015 i underwent treatment for depression using repetitive transcranial magnetic stimulation (rtms) for one hour, five days a week, for six weeks. This was using the neurostar machine. After six weeks my treatment was stopped but my depression did not lessen. A few days after treatment was stopped, i noticed that the tinnitus that i had in my left ear since 2008 was much louder and higher in frequency than before. I also developed hyperacusis and also started noticing tinnitus in my right ear as well. Before my tinnitus was rather mild, but now it was so loud and high pitched that i could hear it over everything. It became difficult to sleep and i even became suicidal.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5058804
MDR Report Key5335596
Date Received2015-12-24
Date of Report2015-12-24
Date of Event2015-08-31
Date Added to Maude2015-12-30
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEUROSTAR TMS THERAPY SYSTEM
Generic NameTRANSCRANIAL MAGNETIC STIMULATION SYSTEM
Product CodeOBP
Date Received2015-12-24
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerNEURONETICS


Patients

Patient NumberTreatmentOutcomeDate
10 2015-12-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.